QL
APGE

Quarry LP’s Apogee Therapeutics APGE Stock Holding History

Quarry LP’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Buy
+160
New +$14.4K ﹤0.01% 833
2026
Q1 		– Sell
-2,500
Closed -$189K – 1423
2025
Q4 		$189K Buy
+2,500
New +$157K 0.03% 282
2025
Q3 		– Sell
-1,930
Closed -$83.8K – 2166
2025
Q2 		$83.8K Buy
+1,930
New +$73.4K 0.02% 634

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Quarry LP's APGE Position: Q2 2026 in Review

Quarry LP opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 160 shares worth $21.2K. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings. This is a return to the name: Quarry LP previously reported a position in APGE as recently as Q4 2025.

Quarry LP first reported a position in APGE in Q2 2025 and has held it in 3 quarters since. The position peaked at $189K in Q4 2025. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Quarry LP held 160 shares of Apogee Therapeutics worth $21.2K as of Q2 2026.
  • Apogee Therapeutics was a new Quarry LP position in Q2 2026.
  • Apogee Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #833 holding.
  • Quarry LP first reported a position in Apogee Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Quarry LP's Apogee Therapeutics position peaked at $189K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.